The HCC imaging no-show rate and HCC imaging delay were shown to be independent risk factors for TTP when accounting for Milan criteria, AFP levels, albumin levels, and first-cycle LDT response rates (Table 4). The gene discussed is AFP; the disease is hepatocellular carcinoma.